Proven to help you lower your A1C‡1

‡1A 20 week, multicenter, randomized clinical trial compared adult and pediatric subjects with type 1 and type 2 diabetes and A1C ≥ 8.0% , followed by a 46 week non-randomized observational study. Patients were randomized to use the OneTouch® UltraSmart® Meter (n=113) or conventional meters and paper logbooks (n=93). Both groups received monthly counseling from health care providers during the 20 week clinical trial and returned to usual care during the observational follow up. In the 20 week study, both groups saw a reduction in A1C; however, the reduction in the OneTouch UltraSmart Group was significantly greater (-0.6 vs. -0.4) (p= 0.03). In the observational study, subjects who chose to continue with the OneTouch UltraSmart Meter (n=42) showed a sustained reduction in A1C over subjects who chose to continue with conventional meters and paper logbooks (n=28), (8.47 vs 9.25, p=0.006). The study did not evaluate whether this change in A1c will result in improved health outcomes.
1. LifeScan data on file: Self-monitoring of blood glucose study number 1: The Ability of People with Diabetes to Use OneTouch® UltraSmart® to Improve Glycemic Control Through Behavioral and Therapeutic Changes (RPT 1039775, Nov. 2004) and Addendum #1 (Nov. 2005).

• Automatically collects and organizes your glucose data by time of day.
• Requires just a speck of blood.
• Results in just 5 seconds, so there’s no waiting.
• Test results are entered automatically into 9 charts and graphs.
• Results easily download for you and your health care professional.
• SmartButtons™ give you the option to enter more information.